Objectives: Time-in-therapeutic range (TTR) assesses safety and effectiveness of warfarin therapy using international normalized ratio (INR). This study aimed to investigate the status of TTR in Hong Kong and patients’ economic and clinical outcomes. Predictors of poor warfarin control and patient’s knowledge in warfarin therapy were assessed. Methods: A five-month observational study was conducted in Prince of Wales Hospital in Hong Kong. The TTRs calculated using Caucasian and Japanese therapeutic range were examined among patients on warfarin for at least one year. Patients’ knowledge was assessed using the Oral Anticoagulation Knowledge (OAK) test. Results: A total of 259 patients were included in this study, with 174 of them completed the OAK test. Using Caucasian therapeutic range, calculated mean TTR was 40.2 ± 17.1%, compared that of 49.1 ± 16.1% with Japanese therapeutic range (P<0.001). Mean TTR in patients with atrial fibrillation was higher than those with prosthetic heart valve (p<0.001). Predictability of TTR on clinical outcomes and economic outcomes was comparable between Caucasian and Japanese therapeutic range. Patients with ideal TTR had fewer clinical complications and lower warfarin-related healthcare costs. Patients with younger age, concurrent use of aspirin, frusemide, famotidine, pantoprazole and simvastatin were associated with poorer TTR. Mean score of OAK test was 54.1%. Only 24 patients (13.8%) achieved the satisfactory overall score of ≥75% in the test. Conclusion: Warfarin use in Hong Kong patients was poorly controlled regardless of indication. Patients’ knowledge towards warfarin use was suboptimal. More education to patients on warfarin use is warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.